Ligand-Free Silver Nanoparticles: An Innovative Strategy against Viruses and Bacteria

Maria Vittoria Morone,Annalisa Chianese,Federica Dell’Annunziata,Veronica Folliero,Erwin Pavel Lamparelli,Giovanna Della Porta,Carla Zannella,Anna De Filippis,Gianluigi Franci,Massimiliano Galdiero,Antonio Morone
DOI: https://doi.org/10.3390/microorganisms12040820
IF: 4.5
2024-04-18
Microorganisms
Abstract:The spread of antibiotic-resistant bacteria and the rise of emerging and re-emerging viruses in recent years constitute significant public health problems. Therefore, it is necessary to develop new antimicrobial strategies to overcome these challenges. Herein, we describe an innovative method to synthesize ligand-free silver nanoparticles by Pulsed Laser Ablation in Liquid (PLAL-AgNPs). Thus produced, nanoparticles were characterized by total X-ray fluorescence, zeta potential analysis, transmission electron microscopy (TEM), and nanoparticle tracking analysis (NTA). A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed to evaluate the nanoparticles’ cytotoxicity. Their potential was evaluated against the enveloped herpes simplex virus type 1 (HSV-1) and the naked poliovirus type 1 (PV-1) by plaque reduction assays and confirmed by real-time PCR and fluorescence microscopy, showing that nanoparticles interfered with the early stage of infection. Their action was also examined against different bacteria. We observed that the PLAL-AgNPs exerted a strong effect against both methicillin-resistant Staphylococcus aureus (S. aureus MRSA) and Escherichia coli (E. coli) producing extended-spectrum β-lactamase (ESBL). In detail, the PLAL-AgNPs exhibited a bacteriostatic action against S. aureus and a bactericidal activity against E. coli. Finally, we proved that the PLAL-AgNPs were able to inhibit/degrade the biofilm of S. aureus and E. coli.
microbiology
What problem does this paper attempt to address?
### Problems the paper attempts to solve This paper aims to solve public health problems caused by antibiotic - resistant bacteria and emerging or re - emerging viruses. Specifically: 1. **Antibiotic - resistant bacteria**: In recent years, infections caused by multi - drug - resistant bacteria have become increasingly serious worldwide, posing a major challenge to public health. In particular, bacteria such as methicillin - resistant Staphylococcus aureus (MRSA) and Escherichia coli producing extended - spectrum β - lactamases (ESBL - E. coli) have developed resistance to traditional antibiotics, making treatment difficult. 2. **Emerging and re - emerging viruses**: For example, the spread of viruses such as herpes simplex virus type 1 (HSV - 1) and poliovirus type 1 (PV - 1) also poses a public health threat. HSV - 1 infections are usually treated with acyclovir, but the emergence of resistant strains has greatly reduced the treatment effect. PV - 1 is mainly prevented by vaccines, but there is still a risk of continuous spread in some areas. ### Solutions To meet these challenges, the paper proposes an innovative method, that is, synthesizing ligand - free silver nanoparticles (PLAL - AgNPs) by pulsed - laser ablation in liquid (PLAL) technology. These nanoparticles have the following features and advantages: 1. **Synthesis method**: The PLAL technology can generate ligand - free silver nanoparticles by laser - ablating a pure silver target in a liquid. This method can precisely control the size and morphology of nanoparticles, avoiding impurity and instability problems common in chemical synthesis methods. 2. **Characterization**: The PLAL - AgNPs were characterized in detail by means of total X - ray fluorescence, ζ - potential analysis, transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA), ensuring their purity and stability. 3. **Antiviral activity**: The antiviral activities of PLAL - AgNPs against HSV - 1 and PV - 1 were evaluated by plaque - reduction assay, real - time PCR and fluorescence microscopy. The results showed that these nanoparticles could effectively interfere with virus replication at the early stage of infection. 4. **Antibacterial activity**: The antibacterial activities of PLAL - AgNPs against MRSA and ESBL - E. coli were evaluated by micro - dilution method, time - kill analysis and biofilm inhibition / degradation test. The results indicated that PLAL - AgNPs showed significant antibacterial effects against these two bacteria, and also had obvious effects on biofilm formation and degradation. ### Conclusions This study demonstrates the potential of a new method for synthesizing ligand - free silver nanoparticles in combating antibiotic - resistant bacteria and viruses. These nanoparticles not only have good stability and biocompatibility, but also show strong antimicrobial activity, providing a new strategy for solving current public health problems.